By Walter F. Roche Jr.
The objection to the liquidation plan for the company blamed for a fatal 2012 fungal meningitis outbreak has been withdrawn just days after it was filed in behalf of a Nevada woman.
The withdrawal of the motion was recorded in U.S. Bankruptcy Court in Massachusetts Wednesday.
The motion had been filed in behalf of Katrina Eldreth, a Nevada woman whose son died after being treated with a heart drug from the New England Compounding Center.
The withdrawal was filed without explanation and Anne Andrews, Eldreth's attorney was not immediately available for comment.
The original motion stated that the requirements for filing a claim against NECC made it impossible for Eldreth to file a claim, even though an expert concluded it was more likely than not that the NECC drug, cardioplegia, was the cause of Ari Gomez death in September of 2012.
According to the motion, the drug lot the 3-year-old was treated with was never tested for contaminants by federal officials, a requirement for filing a claim.